4//SEC Filing
Sivori John P 4
Accession 0001179110-12-004128
CIK 0000916085other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 8:15 PM ET
Size
28.5 KB
Accession
0001179110-12-004128
Insider Transaction Report
Form 4
Sivori John P
Pres, Rgnl Hlth Plns & Pharma
Transactions
- Exercise/Conversion
Common Stock
2012-02-29$28.90/sh+28,000$809,200→ 46,333 total - Sale
Common Stock
2012-02-29$37.86/sh−7,321$277,159→ 18,333 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-02-29−28,000→ 0 totalExercise: $28.90From: 2005-02-17Exp: 2014-02-17→ Common Stock (28,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2012-02-29−7,321→ 17,879 totalExercise: $29.20From: 2006-02-24Exp: 2015-02-24→ Common Stock (7,321 underlying) - Sale
Common Stock
2012-02-29$37.81/sh−28,000$1,058,750→ 18,333 total - Exercise/Conversion
Common Stock
2012-02-29$29.20/sh+7,321$213,773→ 25,654 total - Exercise/Conversion
Common Stock
2012-03-01$29.20/sh+17,879$522,067→ 36,212 total - Sale
Common Stock
2012-03-01$38.22/sh−17,879$683,410→ 18,333 total - Sale
Common Stock
2012-03-01$38.16/sh−8,334$318,025→ 18,333 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-03-01−17,879→ 0 totalExercise: $29.20From: 2006-02-24Exp: 2015-02-24→ Common Stock (17,879 underlying) - Exercise/Conversion
Common Stock
2012-03-01$30.73/sh+8,334$256,104→ 26,667 total - Sale
Common Stock
2012-03-01$38.00/sh−15,770$599,260→ 16,552 total(indirect: By Trust) - Exercise/Conversion
Stock Option (Right to Buy)
2012-03-01−8,334→ 16,666 totalExercise: $30.73From: 2012-02-18Exp: 2018-02-18→ Common Stock (8,334 underlying)
Footnotes (13)
- [F1]Exercise of a stock option granted to the Reporting Person on February 17, 2004 under the Issuer's 1997 Stock Option Plan, as amended (the "2004 Grant"), in a transaction exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Act").
- [F10]Represents unvested and unexercised options from the 2011 Grant beneficially owned by the Reporting Person.
- [F11]The 2004 Grant became exercisable in 25% increments on each of the first, second, third and fourth anniversaries of the grant date of February 17, 2004.
- [F12]The 2005 Grant became exercisable in 25% increments on each of the first, second, third and fourth anniversaries of the grant date of February 24, 2005.
- [F13]Represents vested and unexercised options from the 2005 Grant beneficially owned by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.66 to $38.03625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F3]Exercise of a portion of a 25,200 share stock option grant made to the Reporting Person on February 24, 2005 under the Issuer's 2002 Stock Option Plan, as amended (the "2005 Grant"), in a transaction exempt under the Act.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.68 to $38.035, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.35667, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F6]Exercise of a portion of a 25,000 share stock option grant made to the Reporting Person on February 18, 2011 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2011 Grant"), in a transaction exempt under the Act.
- [F7]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.005 to $38.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F8]Shares held by the Sivori Family Trust, John and Roxanne Sivori TTES (the "Sivori Family Trust"), of which the Reporting Person is a trustee and beneficiary.
- [F9]The 2011 Grant became exercisable with respect to 33-1/3% of the options on the first anniversary of the grant date of February 18, 2011 and will become exercisable with regard to the remainder of the options in 33-1/3% increments on each of the second and third anniversaries of the grant date.
Documents
Issuer
HEALTH NET INC
CIK 0000916085
Entity typeother
Related Parties
1- filerCIK 0001450520
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 8:15 PM ET
- Size
- 28.5 KB